Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Corporate Action-Fixes Record Date For (Interim Dividend)

 Meeting Commencement Time : 10:00 A.M Meeting Conclusion Time : 10:51 A.M The Board of Directors at its meeting held today, considered and approved the following: 1. Declaration of an Interim Dividend for the Financial Year 2022-23 of ? 4.40/- (Rupees Four and forty paise only) per equity share having face value of ? 5/- i.e. 88% aggregating to ? 6,39,26,289/- (Rupees Six Crore Thirty Nine lakhs twenty six thousand two hundred eighty nine only) 2. The Record date for the same is 2nd December,2022 This may be taken as compliance under the Listing Regulations. Kindly take the same on record.
21-11-2022
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Corporate Action-Board approves Dividend

 Meeting Commencement Time : 10:00 A.M Meeting Conclusion Time : 10:51 A.M The Board of Directors at its meeting held today, considered and approved the following: 1. Declaration of an Interim Dividend for the Financial Year 2022-23 of ? 4.40/- (Rupees Four and forty paise only) per equity share having face value of ? 5/- i.e. 88% aggregating to ? 6,39,26,289/- (Rupees Six Crore Thirty Nine lakhs twenty six thousand two hundred eighty nine only) 2. The Record date for the same is 2nd December,2022 This may be taken as compliance under the Listing Regulations. Kindly take the same on record.
21-11-2022
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Board Meeting Outcome for Outcome Of Board Meeting Under Reg. 30 Of SEBI (LODR) Regulations, 2015

 Meeting Commencement Time : 10:00 A.M Meeting Conclusion Time : 10:51 A.M The Board of Directors at its meeting held today, considered and approved the following: 1. Declaration of an Interim Dividend for the Financial Year 2022-23 of ? 4.40/- (Rupees Four and forty paise only) per equity share having face value of ? 5/- i.e. 88% aggregating to ? 6,39,26,289/- (Rupees Six Crore Thirty Nine lakhs twenty six thousand two hundred eighty nine only) 2. The Record date for the same is 2nd December,2022 This may be taken as compliance under the Listing Regulations. Kindly take the same on record.
21-11-2022
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Audio Recording Of The Maiden Earnings Conference Call For Q2 & H1 FY23 Held On 16.11.2022

 Pursuant to Regulation 30 and 46 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that the audio recording of earnings conference call, conducted on November 16, 2022, for the quarter ended September 30, 2022, has been uploaded on the website of the Company at viz., www.gtbl.in
16-11-2022
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Corporate Action-Board to consider Dividend

 With reference to captioned subject this is to inform you that the meeting of Board of Directors of Gujarat Themis Biosyn Ltd. will be held on Monday, 21st November, 2022, inter alia to consider a proposal relating to declaration of Interim Dividend for the financial year 2022-2023, if any. Further, as per Company''s Code of Conduct for Prevention of Insider Trading, framed pursuant to SEBI ( Prohibition of Insider Trading ) Regulation, 2015, the trading window for dealing in the securities of the company will remain closed for specified person from November 16, 2022 to November 23, 2022 (both days inclusive). This is for your information and record.
16-11-2022
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Board Meeting Intimation for Intimation Of Date Of Board Meeting & Closure Of Trading Window.

 GUJARAT THEMIS BIOSYN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/11/2022 ,inter alia, to consider and approve With reference to captioned subject this is to inform you that the meeting of Board of Directors of Gujarat Themis Biosyn Ltd. will be held on Monday, 21st November, 2022, inter alia to consider a proposal relating to declaration of Interim Dividend for the financial year 2022-2023, if any. Further, as per Company''s Code of Conduct for Prevention of Insider Trading, framed pursuant to SEBI ( Prohibition of Insider Trading ) Regulation, 2015, the trading window for dealing in the securities of the company will remain closed for specified person from November 16, 2022 to November 23, 2022 (both days inclusive). This is for your information and record.
16-11-2022
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In terms of Regulation 47 of the SEBI (LODR) Regulations, 2015 the Company has published the Unaudited Financial Results for the quarter and half year ended September 30, 2022 in ''Western Times'' (English) edition dated Tuesday, November 8, 2022 & in ''Western Times'' (Gujarati) edition dated Tuesday, November 8, 2022. Further, in pursuance of Regulation 30 read with Schedule III (A) (12) please find enclosed the copy of Newspaper articles as published in above mentioned newspapers.
09-11-2022
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Announcement under Regulation 30 (LODR)-Investor Presentation

 In terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), we submit herewith the Investors' Presentation of the Company, with respect to Business Overview of Gujarat Themis Biosyn Limited ('the Company'). Further, a copy of the same is also available on the website of the Company, viz., www.gtbl.in
09-11-2022
Bigul

GUJARAT THEMIS BIOSYN LTD. - 506879 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (LODR) Regulation, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company i.e. Link Intime India Private Limited has received below mentioned intimation / request(s) for Loss of Share Certificate(s) / issuance of duplicate share certificate(s) from the following shareholder(s): Sr. No. Name Folio No. Cert. No. Number of Shares Dist. No. From Dist. No. To 1. NAMBERUMAL M 00008943 15500 100 4265901 4266000 We shall issue the duplicate Share Certificate(s) only after the necessary formalities are carried out by the Shareholder(s).
09-11-2022
Bigul

Q2FY23 Quarterly Result Announced for Gujarat Themis Biosyn Ltd.

 Pharmaceutical company Gujarat Themis Biosyn announced Q2FY23 results: Q2FY23 vs Q2FY22: Revenue from operations stood at Rs 47.7 crore in Q2 FY23, as against Rs 35.1 crore in Q2 FY22, rise of 36.1% EBITDA for the quarter was Rs 24.4 crore as against Rs 18.5 crore in Q2 FY22, an increase of 32.3% - EBITDA Margin stood at 51.2% Q2 FY23 Profit stood at Rs 18.7 crore as against profit of Rs 13.8 crore in Q2 FY22 EPS for the quarter stood at Rs 12.87 H1FY23 vs H1FY22: Revenue from operations stood at Rs 92.6 crore in H1 FY23, as against Rs 67.5 crore in H1 FY22, rise of 37.3% EBITDA for the six months was Rs 47.2 crore as against Rs 35.2 crore in H1 FY22, an increase of 34.2% - EBITDA Margin stood at 50.9% H1FY23 Profit stood at Rs 36.5 crore as against a profit of Rs 26.7 crore in H1 FY22 EPS for the period stood at Rs 25.10 Result PDF
09-11-2022
Next Page
Close

Let's Open Free Demat Account